Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Pulmonary Pharmacology & Therapeutics|March 20, 2022
Protective effects of adipose-derived biogenic nanoparticles on the pulmonary microvascular endothelial barrier in mice with ventilator-induced lung injury via the TRPV4/ROCK1 signalling pathwayQian Yu, Daoxin Wang, Shulei Fan, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 5, 2021
High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseJunnan Peng, Qian Yu, Shulei Fan, et al.
Free Radical Biology & Medicine|December 6, 2024
Celastrol ameliorates lipopolysaccharide (LPS)-induced acute lung injury by improving mitochondrial function through AMPK/PGC-1α/Nrf1-dependent mechanismXinyu Deng, Jing He, Wenpeng Deng, et al.
Respiratory Research|January 1, 2015
17β-estradiol suppresses lipopolysaccharide-induced acute lung injury through PI3K/Akt/SGK1 mediated up-regulation of epithelial sodium channel (ENaC) in vivo and in vitroDi Qi, Jing He, Daoxin Wang, et al.
Journal of Clinical Laboratory Analysis|July 19, 2020
Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional studyJunnan Peng, Di Qi, Guodan Yuan, et al.
International Immunopharmacology|February 28, 2026
Rab32-mediated macrophage apoptosis and apoptotic body release promote M1 polarization in ARDS via the Cxcl11/Ccl4/NF-κB pathwayDi Wu, Qian Liu, Xixin Zhou, et al.
Inflammation|July 13, 2019
Protein Kinase C Theta Inhibition Attenuates Lipopolysaccharide-Induced Acute Lung Injury through Notch Signaling Pathway via Suppressing Th17 Cell Response in MiceMengqin Li, Yan Zhao, Jing He, et al.
Clinical Science (London, England : 1979)|March 20, 2025
CGRP alleviates lipopolysaccharide-induced ARDS inflammation via the HIF-1α signaling pathwayRenzi Zhang, Yuhua Zhong, Qiudie Liu, et al.
Immunology Letters|November 26, 2013
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates airway inflammation by inhibiting the proliferation of effector T cells in a murine model of neutrophilic asthmaYan Zhao, Yi Huang, Jing He, et al.
BMC Pulmonary Medicine|November 23, 2017
Effect of sivelestat sodium in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of randomized controlled trialsShenglan Pu, Daoxin Wang, Daishun Liu, et al.
Pageof 8